These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 6153668)

  • 21. Properties of an immunogenic fraction from Brucella abortus 45/20.
    Corbel MJ; Redwood DW
    Dev Biol Stand; 1984; 56():159-68. PubMed ID: 6436092
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Studies on the polysaccharide B and native haptene of Brucella and Yersinia enterocolitica serotype 9.
    Diaz R; Toyos J; Salvo MD; Fernandez-Lago L; Alonso B; Moriyon I; Dorronsoro I
    Dev Biol Stand; 1984; 56():213-20. PubMed ID: 6436095
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Isolation of Brucella abortus total RNA from B. abortus-infected murine RAW macrophages.
    Covert J; Eskra L; Splitter G
    J Microbiol Methods; 2005 Mar; 60(3):383-93. PubMed ID: 15649540
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Brucella melitensis Rev. 1 and Brucella abortus 45-20 vaccines in goats: pattern of immunoglobulin production after vaccination and challenge.
    Varela-Diaz VM; Jones LM; Perez-Esandi MV
    Am J Vet Res; 1973 Feb; 34(2):203-7. PubMed ID: 4631097
    [No Abstract]   [Full Text] [Related]  

  • 25. The chemical mediation of delayed hypersensitivity skin reactions. I. Purification of a macrophage-chemotactic factor from bovien gamma-globulin-induced skin reactions in guinea pigs.
    Kambara T; Ueda K; Maeda S
    Am J Pathol; 1977 May; 87(2):359-74. PubMed ID: 66878
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An enzyme immunoassay for bovine brucellosis using a monoclonal antibody specific for field strains of Brucella abortus.
    Gorrell MD; Milliken GL; Anderson BJ; Pucci A
    Dev Biol Stand; 1984; 56():491-4. PubMed ID: 6436107
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Structure and biological properties of antigens isolated from Brucella].
    Dranovskaia EA; Vershilova PA; Chernysheva MI; Kniazeva EN
    Zh Mikrobiol Epidemiol Immunobiol; 1972 Apr; 49(4):85-8. PubMed ID: 5028455
    [No Abstract]   [Full Text] [Related]  

  • 28. [Immunological properties of a phenol-insoluble extract from Brucella melitensis (P.I. fraction)].
    Roux J; Asselineau J; Serre A; Lacave C
    Ann Inst Pasteur (Paris); 1967 Sep; 113(3):411-23. PubMed ID: 6048204
    [No Abstract]   [Full Text] [Related]  

  • 29. Studies of Brucella lipopolysaccharide.
    Jones LM; Berman DT
    Dev Biol Stand; 1976; 31():62-7. PubMed ID: 1261751
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunization against Brucella infections: serological and immunological studies on a soluble antigen from Brucella melitensis.
    Chen TH; Elberg SS
    J Infect Dis; 1969 Aug; 120(2):143-52. PubMed ID: 4980600
    [No Abstract]   [Full Text] [Related]  

  • 31. RNA isolation and fractionation with compaction agents.
    Murphy JC; Fox GE; Willson RC
    Anal Biochem; 2001 Aug; 295(2):143-8. PubMed ID: 11488615
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antigens of Brucella suis. I. Effect of physical & chemical agents.
    Joshi DV; Prakash O
    Indian J Exp Biol; 1972 Sep; 10(5):365-7. PubMed ID: 4633124
    [No Abstract]   [Full Text] [Related]  

  • 33. Dissociation of delayed-type hypersensitivity from acquired murine resistance to Brucella suis.
    Escande A; Cannat A; Serre A
    Ann Immunol (Paris); 1980; 131D(2):199-204. PubMed ID: 7469385
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Antigenicity of uvea constituents].
    Urgancioglu M; Halpern B; Parlebas J; Rebeyrotte P
    Rev Immunol (Paris); 1970; 34(3):85-97. PubMed ID: 4989941
    [No Abstract]   [Full Text] [Related]  

  • 35. A potency assay for brucella allergens in guinea pigs.
    Jones LM
    Dev Biol Stand; 1976; 31():165-70. PubMed ID: 1261735
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fractionation and immunological properties of a DNA-rich preparation from Brucella abortus.
    PLESCIA OJ; NOVAL JJ; PALCZUK NC; BRAUN W
    Proc Soc Exp Biol Med; 1961 Apr; 106():748-52. PubMed ID: 13736320
    [No Abstract]   [Full Text] [Related]  

  • 37. A study of immunological cross-reaction between Yersinia enterocolitica 0:9 and Brucella abortus.
    Jian H; Chu TP
    Dev Biol Stand; 1984; 56():179-83. PubMed ID: 6436093
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Aspects related to the antigenic structure and serological specificity of brucellae phylogenetically related to S- and R-forms and dissociated into R-variants].
    Peshkov I
    Vet Med Nauki; 1978; 15(9):34-40. PubMed ID: 88791
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A study of gel diffusion test and immunoelectrophoresis on Brucella antigen--sonic extract.
    Kulshrestha RC; Atal PR; Wahi PN
    Indian J Pathol Bacteriol; 1969 Jul; 12(3):109-13. PubMed ID: 4986510
    [No Abstract]   [Full Text] [Related]  

  • 40. The bovine immune response to Brucella abortus I. A water soluble antigen precipitated by sera of some naturally infected cattle.
    Stemshorn B; Nielsen K
    Can J Comp Med; 1977 Apr; 41(2):152-9. PubMed ID: 405088
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.